Journal of Personalized Medicine (Jun 2022)

Shock Index Is a Validated Prediction Tool for the Short-Term Survival of Advanced Cancer Patients Presenting to the Emergency Department

  • Zhong Ning Leonard Goh,
  • Mu-Wei Chen,
  • Hao-Tsai Cheng,
  • Kuang-Hung Hsu,
  • Chen-Ken Seak,
  • Joanna Chen-Yeen Seak,
  • Seng Kit Ling,
  • Shao-Feng Liao,
  • Tzu-Heng Cheng,
  • Yi-Da Sie,
  • Chih-Huang Li,
  • Hsien-Yi Chen,
  • Cheng-Yu Chien,
  • Chen-June Seak,
  • SPOT Investigators

DOI
https://doi.org/10.3390/jpm12060954
Journal volume & issue
Vol. 12, no. 6
p. 954

Abstract

Read online

Advanced cancer patients who are not expected to survive past the short term can benefit from early initiation of palliative care in the emergency department (ED). This discussion, however, requires accurate prognostication of their short-term survival. We previously found in our retrospective study that shock index (SI) is an ideal risk stratification tool in predicting the 60-day mortality risk of advanced cancer patients presenting to the ED. This study is a follow-up prospective validation study conducted from January 2019 to April 2021. A total of 410 advanced cancer patients who presented to the ED of a medical centre and could be followed-up feasibly were recruited. Univariate and multivariable logistic regression analyses were performed with receiver operator calibrating (ROC) curve analysis. Non-survivors had significantly lower body temperatures, higher pulse rates, higher respiratory rates, lower blood pressures, and higher SI. Each 0.1 increment of SI increased the odds of 60-day mortality by 1.591. Area under ROC curve was 0.7819. At optimal cut-off of 0.94, SI had 66.10% accuracy. These results were similar to our previous study, thus validating the use of SI in predicting the 60-day mortality of advanced cancer patients presenting to the ED. Identified patients may be offered palliative care.

Keywords